Efficacy and Safety of Ponatinib as a Second‑Line Treatment for Chronic‑Phase Chronic Myeloid Leukemia: Retrospective Study at Two Japanese CentersYoshimi Ishii, Hideaki Nakajima, Shin Fujisawa et al.|Indian Journal of Hematology and Blood Transfusion|2026Cited by 0
[Fertility preservation and treatment outcomes in female patients with chronic-phase chronic myeloid leukemia: a single-institution experience].Itaru Sato, Hideaki Nakajima, Yoshimi Ishii et al.|PubMed|2026Cited by 0